Literature DB >> 3373594

Morphometric and clinical studies on 68 consecutive radical prostatectomies.

T A Stamey1, J E McNeal, F S Freiha, E Redwine.   

Abstract

Morphometric reconstructions of 68 consecutive radical prostatectomies were analyzed for cancer volume, extent of complete capsular penetration, microscopic seminal vesicle and lymph node invasion, and histological differentiation, all of which were strongly interrelated. At less than 3.0 cc cancer volume, only 6 of 34 prostates (18 per cent) showed capsular penetration compared to 27 of 34 (79 per cent) with tumors of greater than 3.0 cc. Seminal vesicle invasion occurred once in 34 tumors of less than 3.0 cc and 15 times in those greater than 3.0 cc. All 6 patients with metastases to lymph nodes, 2 with early postoperative development of bone metastases and 4 of 5 with reappearance of detectable prostate specific antigen postoperatively had cancer volumes of greater than 4.0 cc. Correlation of digital rectal examination with cancer volume showed that of 39 palpable nodules in prostates with a cancer volume of less than 4.0 cc 30 (77 per cent) occupied 50 per cent or less of the length of 1 lobe (clinical stage B1 in our classification). Of 22 palpable lesions in tumors of greater than 4.0 cc 21 (95 per cent) exceeded 50 per cent of 1 lobe in the longitudinal extension (stage B2) or they represented bilaterally palpable disease (stage B3). Capsular penetration into the periprostatic fat occurred most commonly in the dorsolateral area of the neurovascular bundle, including 10 of 12 tumors less than 4.0 cc in volume (stage B1) and 19 of 21 with greater than 4.0 cc in tumor volume (stages B2 and B3). All 10 of the stage B1 cancers were free of contralateral lobe capsular penetration while 1 of the 13 stage B2 nodules had minimal contralateral capsule penetration in the area of the neurovascular bundle. We believe that the modified nerve-sparing radical prostatectomy should be limited to the contralateral side in stage B disease.

Entities:  

Mesh:

Year:  1988        PMID: 3373594     DOI: 10.1016/s0022-5347(17)42876-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  36 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre study.

Authors:  Alexandra Masson-Lecomte; Vincent Hupertan; Eva Comperat; Christophe Vaessen; Emmanuel Chartier-Kastler; Olivier Cussenot; Marc-Olivier Bitker; Morgan Rouprêt
Journal:  World J Urol       Date:  2010-11-12       Impact factor: 4.226

3.  [Decreased number of R1-resections in radical retropubic prostatectomy. Use of a newly developed fast sectioning technique].

Authors:  P M Braun; K Meyer-Schell; C Seif; S Hautmann; I Leuschner; G Klöppel; K-P Jünemann
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

4.  Tissue shrinkage after fixation with formalin injection of prostatectomy specimens.

Authors:  Sara Jonmarker; Alexander Valdman; Anna Lindberg; Magnus Hellström; Lars Egevad
Journal:  Virchows Arch       Date:  2006-08-15       Impact factor: 4.064

5.  Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).

Authors:  Theodorus H van der Kwast; Laurence Collette; Hein Van Poppel; Paul Van Cangh; Kris Vekemans; Luigi DaPozzo; Jean-François Bosset; Karl H Kurth; Fritz H Schröder; Michel Bolla
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

6.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

Review 7.  Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance.

Authors:  Rodolfo Montironi; Roberta Mazzucchelli; Theodorus Kwast
Journal:  Virchows Arch       Date:  2003-01-16       Impact factor: 4.064

Review 8.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

9.  Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.

Authors:  Axel Krieger; Sang-Eun Song; Nathan B Cho; Iulian Iordachita; Peter Guion; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE ASME Trans Mechatron       Date:  2011-10-17       Impact factor: 5.303

10.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.